ABRAXANE
5MG/ML INF PLV DIS 1X100MG
Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
---|---|---|---|---|
Placing on the market | 20.01.2012 | |||
Resumption of marketing | 02.03.2022 | |||
Interruption of marketing | 12.01.2022 |
0238472 |
Capacity/distribution reasons | 14.03.2022 |
All reports are available in the Overview.